A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and bipartisan health care challenges. The blog highlights how the 340B program helps keep drug prices lower than they otherwise would be for all stakeholders; helps lower national expenditures on health care services; and helps protect the safety net for Americans.

“The 340B program was created over 30 years ago with strong bipartisan congressional support and it ought to be preserved in the same manner,” the blog states. “We urge Congress to not allow the self-interested needs of the pharmaceutical industry to supplant the needs of patients and communities across this country who rely on the 340B program for access to affordable, high-quality health care every day.”

Headline
The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public Health Service Act does not …
Headline
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…